Research Analysts' Recent Ratings Updates for Flexion Therapeutics (FLXN)

Research Analysts' Recent Ratings Updates for Flexion Therapeutics (FLXN)

The Company is targeting antiinflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United States. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the

(Visited 1 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.